SEC Tracker
Get the app

CRISPR Therapeutics CRSP

Samarth Kulkarni (CEO) sold 47,837 CRSP at $49.78, worth $2.4M

Form
4
Filed
Importance
Routine
  1. Executed 100,000 common shares on Oct 16, 2026
  2. Sold 47,837 common shares on Oct 19, 2026
  3. Restricted stock units (shares paid out over time) granted on Oct 16, 2024
  4. Vesting schedule over 2025-2028

Written from the Form 4 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when CRISPR Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Soleno Therapeutics SLNO public float $4.1B, Jun 30, 2025
  2. Adma Biologics ADMA public float $4.2B, Jun 30, 2025
  3. Lantheus Holdings LNTH public float $4.3B, Jun 30, 2025
  4. Merus MRUS
  5. Axsome Therapeutics AXSM public float $4.4B, Jun 30, 2025